Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Liver Cancer

7 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Diagnostic

VICCGI14124

03/13/2015

PET Imaging of Hepatocellular Carcinoma with 18F-FSPG

Diagnostic

VICCGI1343

02/06/2014

Multi-Parametric 3 Tesla Magnetic Resonance Imaging (MRI) of Response to Transarterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma (HCC)

Other

VICCGI1523

07/01/2015

Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Registry

Treatment

VICCGI1586

07/31/2015

A Humanitarian Device Exemption Treatment Protocol of TheraSphere? for Treatment of Primary Liver Cancer

Treatment

VICCMD1188

06/08/2012

An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers

Treatment

CTSUGI80702-M

05/05/2011

A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or placebo for patients with Resected Stage III Colon Cancer

Treatment

CTSUGIC80802-M

12/07/2010

Phase III randomized study of sorafenib (IND 69896, NSC 724772) plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)